Result: S235: A two-part, single- and two-arm randomized, open-label study to evaluate the safety, tolerability and pharmacokinetics of the S1P receptor modulator KRP203 in subjects with hematological malignancies

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2024

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

ISSN: 2572-9241

*DOI*:

10.1097/01.hs9.0000843832.53729.72

*Result*: S235: A two-part, single- and two-arm randomized, open-label study to evaluate the safety, tolerability and pharmacokinetics of the S1P receptor modulator KRP203 in subjects with hematological malignancies